[1] Reveille JD, Sims AM, Danoy P, Evans DM, Leo P, Pointon JJ, Jin R, Zhou X, Bradbury LA, Appleton LH, Davis JC, Diekman L, Doan T, Dowling A, Brown MA. Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat Genet, 2010, 42(2): 123-127.[2] Braun J, Bollow M, Remlinger G, Eggens U, Rudwaleit M, Distler A, Sieper J. Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum, 1998, 41(1): 58-67.[3] Zhernakova A, van Diemen CC, WiJmenga C. Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nat Rev Genet, 2009, 10(1): 43-55.[4] 顾鸣敏, 袁文涛, 杨珏琴, 张静, 熊晓燕, 姚芳娟, 陆振虞, 王铸钢, 黄薇, 范丽安. 全基因组扫描寻找强直性脊柱炎的易感基因位点. 遗传学报, 2004, 31(3): 217-220.[5] Brown MA, Pile KD, Kennedy LG, Campbell D, Andrew L, March R, Shatford JL, Weeks DE, Calin A, Words-worth BP. A genome-wide screen for susceptibility loci in ankylosing spondylitis. Arthritis Rheum, 1998, 41(4): 588-595.[6] Laval SH, Timms A, Edwards S, Bradbury L, Brophy S, Milicic A, Rubin L, Siminovitch KA, Weeks DE, Calin A, Wordsworth BP, Brown MA. Whole-genome screening in ankylosing spondylitis: evidence of non-MHC genetic- susceptibility loci. Am J Hum Genet, 2001, 68(4): 918-926.[7] Plenge RM, Cotsapas C, Davies L, Price AL, de Bakker PIW, Maller J, Pe'er I, Burtt NP, Blumenstiel B, DeFelice M, Parkin M, Barry R, Winslow W, Altshuler D. Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. Nat Genet, 2007, 39(12): 1477-1482.[8] Burton PR, Clayton DG, Cardon LR, Craddock N, Delou-kas P, Duncanson A, Kwiatkowski DP, McCarthy MI, Ouwehand WH, Samani NJ, Todd JA, Donnelly P, Barrett JC, Davison D, Easton D, Walker NM. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet, 2007, 39(11): 1329-1337.[9] Karason A, Gudjonsso JE, Upmanyu R, Antonsdottir AA, Hauksson VB, Runasdottir EH, Jonsson HH, Gudbjartsson DF, Frigge ML, Kong A, Stefansson K, Valdimarsson H, Gulcher JR.A susceptibility gene for psoriatic arthritis maps to chromosome 16q: evidence for imprinting. Am J Hum Genet, 2003, 72(1): 125-131.[10] 王雅文, 朱小泉, 宋玉国, 孙亮, 杨泽. 吉林人群强直性脊柱炎6号染色体短臂上的HLA区域遗传易感基因定位研究. 遗传, 2007, 29(7): 805-812.[11] Goie The HS, Steven MM, van der Linden SM, Cats A. Evaluation of diagnostic criteria for ankylosing spondy-litis: A comparison of the Rome, New York and modified New York criteria in patients with a positive clinical his-tory screening test for ankylosing spondylitis. Br J Rheumatol, 1985, 24(3): 242-249.[12] Calin A, Marder A, Becks E, Burns T. Genetic differences between B27 positive patients with ankylosing spondylitis and B27 positive healthy controls. Arthritis Rheum, 1983, 26(12): 1460-1464.[13] van der Linden S, Valkenburg H, Cats A. The risk of developing ankylosing spondylitis in HLA-B27 positive in-dividuals: a family and population study. Br J Rheumatol, 1983, 22(4): 18-19.[14] Paul NL, Ruddle NH. Lymphotoxin. Annu Rev Immunol, 1988, 6(4): 407-438.[15] Banks TA, Rickert S, Ware CF. Restoring immune defenses via lymphotoxin signaling: lessons from cy-tomegalovirus. Immunol Res, 2006, 34(3): 243-254.[16] Trabetti E, Patuzzo C, Malerba G, Galavotti R, Martinati LC, Boner AL, Pignatti PF. Association of a lymphotoxin alpha gene polymorphism and atopy in Italian families. J Med Genet, 1999, 36(4): 323-325.[17] Migita O, Noguchi E, Koga M, Jian Z, Shibasaki M, Migita T, Ito S, Ichikawa K, Matsui A, Arinami T. Haplotype analysis of a 100 kb region spanning TNF-LTA identifies a polymorphism in the LTA promoter region that is associated with atopic asthma susceptibility in Japan. Clin Exp Allergy, 2005, 35(6): 790-796.[18] Balding J, Kane D, Livingstone W, Mynett-Johnson L, Bresnihan B, Smith O, FitzGerald O. |